Daewoong pharmaceutical Co.,Ltd reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 350,191.47 million compared to KRW 322,058.59 million a year ago. Net income was KRW 24,742.32 million compared to KRW 17,467.83 million a year ago. Basic earnings per share from continuing operations was KRW 2,150 compared to KRW 1,578 a year ago. Basic earnings per share was KRW 2,150 compared to KRW 1,578 a year ago.
For the six months, sales was KRW 3,975.36 million compared to KRW 862.2 million a year ago. Net income was KRW 40,151.63 million compared to KRW 31,086.54 million a year ago. Basic earnings per share from continuing operations was KRW 3,540 compared to KRW 2,808 a year ago. Basic earnings per share was KRW 3,540 compared to KRW 2,808 a year ago.